EUVIMEDEUVIMED entdecken
Crossref

Prevalence and outcome of secondary hypogonadism in male patients with Cushing's syndrome and mild autonomous cortisol secretion

Elisabeth Nowak iD, Frederick Vogel iD, Leah Braun iD, Stephanie Zopp, German Rubinstein iD, Katharina Schilbach iD, Martin Bidlingmaier iD, Petra Zimmermann, Jun Thorsteinsdottir iD, Júnia R O L Schweizer iD, Katrin Ritzel iD, Felix Beuschlein iD und 1 weitere

European Journal of Endocrinology · 2024

DOI: 10.1093/ejendo/lvae097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Elisabeth Nowak und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine IV, LMU University Hospital, LMU Munich, 80336 Munich, Germany. Hauptthemen laut MEDLINE: Hypogonadism, Cushing Syndrome, Hydrocortisone, Testosterone. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: German Cushing's Registry CUSTODES, Else Kröner-Fresenius-Stiftung, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Secondary hypogonadism (SH) is common in men with Cushing's syndrome (CS), but its impact on comorbidities is largely unknown and longitudinal data are scarce. If SH also affects men with mild autonomous cortisol secretion (MACS) is unknown.

Methods

We included 30 treatment-naïve adult men with CS and 17 men with MACS diagnosed since 2012. Hypogonadism was diagnosed based on total testosterone (TT) concentrations < 10.4 nmol/L and age-specific cut-offs. Outcomes were compared to age- and BMI-matched controls. In 20 men in remission of CS, a longitudinal analysis was conducted at 6, 12, and 24 months.

Results

Men with CS had significantly lower concentrations of TT, bioavailable T, and free T compared to controls (P < .0001) with lowest concentrations in ectopic CS. Likewise, TT was lower in men with MACS compared to controls. At baseline, 93% of men with CS and 59% of men with MACS had SH. Testosterone correlated negatively with late night salivary cortisol and serum cortisol pre- and post-1 mg dexamethasone suppression test. Following successful surgery, TT increased significantly (P = .001), normalising within 6 months. Despite normalisation, several RBC parameters remained lower in men with CS even 2 years after successful surgery.

Conclusions

Secondary hypogonadism is common in men with CS and MACS but usually reversible after successful surgery. The persisting changes observed in RBC parameters need to be further investigated in larger cohorts and longer follow-up durations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypogonadismCushing SyndromeHydrocortisoneTestosteroneHumansMaleMiddle AgedAdultPrevalenceLongitudinal StudiesTreatment OutcomeAged

Stichwörter der Autor:innen

Cushing's syndromecortisolhypogonadismmild autonomous cortisol secretiontestosterone

Substanzen

HydrocortisoneTestosterone

Autor:innen und Institutionen

  • Department of Medicine IV, LMU University Hospital, LMU Munich, 80336 Munich, Germany.
  • Deggendorf Institute of Technology, 94469 Deggendorf, Germany.
  • Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, 80336 Munich, Germany.
  • Department of Neurosurgery, LMU University Hospital, LMU Munich, 80336 Munich, Germany.
  • Department of Endocrinology, Diabetology, and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), 8091 Zurich, Switzerland.
  • The LOOP Zurich-Medical Research Center, 8044 Zurich, Switzerland.

ORCID-Profile: Elisabeth Nowak, Frederick Vogel, Leah Braun, German Rubinstein, Katharina Schilbach, Martin Bidlingmaier, Jun Thorsteinsdottir, Júnia R O L Schweizer, Katrin Ritzel, Felix Beuschlein, Martin Reincke

Förderung

  • German Cushing's Registry CUSTODES
  • Else Kröner-Fresenius-Stiftung
  • Deutsche Forschungsgemeinschaft
  • Clinician Scientist Program RISE
  • Eva Luise und Horst Köhler Stiftung
  • Munich Clinician Scientist Program
  • LMU Hospital Munich
  • German Cushing’s Registry CUSTODES

Zitieren

APA

Nowak, E., Vogel, F., Braun, L., Zopp, S., Rubinstein, G., Schilbach, K., Bidlingmaier, M., Zimmermann, P., Thorsteinsdottir, J., R O L Schweizer, J., Ritzel, K., Beuschlein, F., & Reincke, M. (2024). Prevalence and outcome of secondary hypogonadism in male patients with Cushing's syndrome and mild autonomous cortisol secretion. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae097

Vancouver

Nowak E, Vogel F, Braun L, Zopp S, Rubinstein G, Schilbach K, et al. Prevalence and outcome of secondary hypogonadism in male patients with Cushing's syndrome and mild autonomous cortisol secretion. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae097

BibTeX
@article{Nowak2024,
  author = {Nowak, Elisabeth and Vogel, Frederick and Braun, Leah and Zopp, Stephanie and Rubinstein, German and Schilbach, Katharina and Bidlingmaier, Martin and Zimmermann, Petra and Thorsteinsdottir, Jun and R O L Schweizer, Júnia and Ritzel, Katrin and Beuschlein, Felix and Reincke, Martin},
  title = {Prevalence and outcome of secondary hypogonadism in male patients with Cushing's syndrome and mild autonomous cortisol secretion},
  journal = {European Journal of Endocrinology},
  year = {2024},
  doi = {10.1093/ejendo/lvae097}
}
Kostenlos starten →